AGATE, LAURA Statistiche

AGATE, LAURA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 115 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 1-gen-2016 Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 1-gen-2015 Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R.
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal 1-gen-2002 Pacini, F; Molinaro, Eleonora; Castagna, Mg; Lippi, F; Ceccarelli, C; Agate, Laura; Elisei, Rossella; Pinchera, Aldo
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 1-gen-2017 Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 1-gen-2020 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 1-gen-2021 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 1-gen-2013 D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 1-gen-2005 Elisei, Rossella; Vivaldi, A; Agate, Laura; Ciampi, R; Molinaro, Eleonora; Piampiani, P; Romei, Cristina; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Capodanno, A; Collecchi, P; Pacini, F; Pinchera, Aldo
All-trans Retinoic Acid treatment inhibits the growth of RARb mRNA expressing thyroid cancer cell lines but does not re-induce the expression of thyroid specific genes 1-gen-2004 Agate, Laura; Vivaldi, A; Ciampi, R; Molinaro, Eleonora; Pacini, F; Pinchera, Aldo; Elisei, Rossella
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 1-gen-2017 Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 1-gen-2010 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? 1-gen-2021 Campopiano, Maria Cristina; Matrone, Antonio; Rago, Teresa; Scutari, Maria; Prete, Alessandro; Agate, Laura; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 1-gen-2012 Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST 1-gen-2021 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line 1-gen-2012 Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. 1-gen-2012 Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 1-gen-2018 Matrone, Antonio; Latrofa, Francesco; Torregrossa, Liborio; Piaggi, Paolo; Gambale, Carla; Faranda, Alessio; Ricci, Debora; Agate, Laura; Molinaro, Eleonora; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Ciglitazone induces cell growth inhibition in a medullary thyroid carcinoma cell line (TT) likely by an increase of PPARgamma expression 1-gen-2003 Romei, Cristina; Cosci, Barbara; Vivaldi, A; Bottici, Valeria; Sculli, M; Molinaro, E; Agate, Laura; Castagna, Mg; Pacini, F; Pinchera, Aldo; Elisei, Rossella
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 1-gen-2017 Ciampi, Raffaele; Romei, Cristina; Pieruzzi, Letizia; Tacito, Alessia; Molinaro, E.; Agate, Laura; Bottici, Valeria; Casella, F.; Ugolini, C.; Materazzi, Gabriele; Basolo, Fulvio; Elisei, Rossella
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 1-gen-2014 Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina